A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
NCT00989313
·
clinicaltrials.gov ↗
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Actinic Keratosis
Interventions
DRUG:
Lesion count
Sponsor
Peplin